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ABSTRACT 
Objective: The present study was planned to develop thermo-reversible in-situ gel for the treatment of allergic rhinitis (AR). The objective of the 
present investigation was to develop a mucoadhesive in-situ gel with reduced nasal mucocilliary clearance to improve the local effect of the 
polyherbal extract in the treatment of allergic rhinitis (AR). The prolonged residence of drug formulation in the nasal cavity is one of utmost 
importance for intranasal drug delivery. The prepared formulations were subjected for gelling temperature, gelling time, viscosity, gel strength, pH, 
drug content, mucoadhesive strength, spread ability and irritancy studies.  
Methods: In the study the pluronic F127 (PF127) based mucoadhesive in-situ nasal gels containing Moringa olifera (MO) and Embelia ribes (ER) 
extracts were used having antioxidant and anti-inflammatory effect. A polyherbal thermosensitive in-situ hydrogel was designed and evaluated by 
the mixing of pluronic F127, poly (ethylene glycol) (PEG400) and Xanthan gum with a small amount of (hydroxypropyl methylcellulose) HPMC K4M 
and Carbopol 934. Total 13 thermosensitive in-situ gels of extracts were prepared through combination of HPMC K4M or Carbopol or xanthan gum 
and PF127. All the preparations were investigated, and the selected method for gel formation underwent the thermal transition from sol to 
hydrogel.  
Results: The mucoadhesive gel after being administered into the nasal cavity, get transformed into the viscous hydrogel at body temperature, which 
diminished nasal mucociliary clearance and prolonged the duration of action. The in-situ nasal herbal gel prepared by combination of different 
concentration of to HPMC K4M or carbopol or xanthan gum with PF127 (10% w/v) produces the better and effective gel. The findings of evaluation 
parameter indicate that the in-situ gel prepared by combination with corbopol were better quality compared to HPMC K4M and xanthan gum. 
Conclusion: From these findings, it can be concluded that in-situ herbal nasal gels may be potential drug delivery systems for Moringa olifera and 
Embelia ribes extracts to overcome first-pass metabolism and thereby to improve the bioavailability. The mucoadhesive in-situ gel system is a 
promising approach for the intranasal delivery of polyherbal extracts for the therapeutic effects improvement of Allergic rhinitis. 
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Allergic rhinitis (AR) is a heterogeneous disorder, which is often 
characterized by mucosal infiltration and actions of eosinophils, 
plasma cells, and mast cells. This disorder is extremely widespread 
but its diagnosis and prevention is very poor. Presently, various 
types of drug formulations for Allergic rhinitis are available. The 
practices of nasal formulation are limited due to associate 
constraints with drug delivery systems poses a major drawback. The 
factors affecting the drug delivery system comprise volume of the 
nasal cavity for the drug volume (<0.2 ml), mucociliary clearance, 
and anterior discharge [1-3]. 
Generally synthetic antihistamines are used to provide symptomatic 
relief to allergic symptoms due to histamine release. The synthetic 
drugs are associated with various types of side effects [4]. Herbal 
medicines have been widely used all over the world since ancient 
times and have been recognized by physicians and patients for their 
better therapeutic value as they have fewer adverse effects as 
compared with modern medicines. Natural molecules derived from 
plant extracts offer a particularly exciting avenue for further 
research. Plant extracts, however, are often ill-defined as to the 
method of extraction, plant-to-solvent ratio and the content of active 
ingredients. Moreover, the stability of the colour, odour, 
transparency and/or active ingredients with time is also often a 
limiting factor [5, 6]. Plant extracts are different in several respects 
from purified therapeutic agents. Firstly, they are more dilute than 
the pure chemicals that are familiar to us; secondly herbs often 
contain additional active principles that may be closely related both 
chemically and therapeutically to the constituent primarily 
responsible for its effects. 
In recent years, the novel in-situ gelling formulations are 
progressing rapidly especially in the field of nasal drug delivery. 
There is an increase in the number of in-situ forming systems has 
been formulated and developed for the various biomedical 
parameters out of the different preparations the thermally induced 
gelling systems had to be the most challenging one, for the 
development of nasal drug delivery systems. The nasal mucosa has 
seriously emerged as a therapeutically viable route for the systemic 
drug delivery. In addition, intranasal absorption avoids the 
gastrointestinal and hepatic presystemic metabolism, enhancing 
drug [8]. 
Phytotherapeutics need a scientific 
approach to deliver the components in a sustained manner to 
increase patient compliance and avoid repeated administration [7].  
Among the different nasal drug delivery systems, in-situ gel 
formulations have been explored for both local and systemic drug 
delivery. These drug delivery systems exist in sol form before their 
administration; however, once administered, they undergo gelation 
to form a gel. The factors regulating the in-situ gel formation process 
include microenvironment temperature, changes in pH, presence of 
ions, ultraviolet irradiation, and polymers. Rheological properties of 
gels, which are critical to their efficacy, are important in retaining 
the gel at the site of application or absorption [9]. The plant used in 
formulation was selected based on scientifically reported property. 
In the present study we have selected Moringa olifera (MO) and 
Embelia ribes (ER) for the formulation of herbal nasal gel. Therefore, 
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an attempt has been made to formulate pluronic F127 (PF127) 
based mucoadhesive in-situ nasal gels containing Moringa olifera 
and Embelia ribes to enhance its therapeutic effect.  
MATERIALS AND METHODS  
Materials 
Moringa olifera fresh leaves were collected and dried; Embelia ribes 
fruit (dreid) were brought from local market. The leaves and seeds 
were authenticated by State Ayurvedic College Lucknow with 
specimen no. 17 and 19 respectively. Pluronic F127 (PF127) was 
supplied from Sigma Aldrich Pvt. Ltd India, hydroxypropyl 
methylcellulose K4M, Xanthan gum, and Carbopol 934 were from 
SDFCL Pvt Ltd. India. All the other chemicals and reagents used in 
this study were of analytical grade. 
Methods 
Air dried and coarsely powdered (500 gm) of Moringa olifera leaves 
and Embelia ribes fruits, were weighed and their hydroalcoholic 
extracts were prepared separately, by using distilled water and 
ethanol. The extracts were then concentrated to dryness under 
reduced pressure and controlled temperature, respectively and they 
were preserved in a refrigerator. 
Preparation of extracts 
Preparation of thermorevresible in-situ nasal polyherbal gel by 
cold method  
The thermorevresible nasal in-situ gel formulation was prepared by 
cold method [10]. For preparation of PF127 solutions, the required 
amount of polymer was dispersed in distilled, deionized water with 
continuous stirring for 1 h. The partially dissolved pluronic solutions 
were stored in the refrigerator until the polymer was completely 
dissolved (approximately 24 h). The preparation of hydroxypropyl 
methylcellulose K4M solution is the same as that of PF127. The 
carbopol 934/pluronic F127 mixed solutions, hydroxypropyl 
methylcellulose K4M/PF127 and xanthan gum/PF127 mixed 
solutions were prepared by dispersing the required amount of 
PF127in the desired concentration of carbopol 934 or HPMC K4M 
with continuous stirring for 1 h, respectively. Different isotonicity 
agents, benzalkonium chloride (Fisher Scientific. India.) (as 
preservative) and the desired amount of Moringa olifera (2%w/w) 
and Embelia ribes (2%w/w) were added in the solution. The samples 
were then allowed to equilibrate at 4 °C overnight (24 h at least) 
[11]. The composition of nasal gel is given in (table 1).  
 
Table 1: Composition of different thermoreversible in-situ nasal polyherbal gels 
Ingredients Formulations 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 
MO (%w/v)  2 2 2 2 2 2 2 2 2 2 2 2 2 
ER (%w/v)  2 2 2 2 2 2 2 2 2 2 2 2 2 
Pluronic F127 (%w/v) 16 14 12 10 10 10 10 10 10 10 10 10 10 
Carbopol 934 (%w/v) - - - - 0.5 1.0 1.5 - - - - - - 
Hydroxypropyl methylcellulose K4M(%w/v) - - - - - - - 0.5 1.0 1.5 - - - 
Xanthan gum (%w/v) - - - - - - - - - - 0.5 1.0 1.5 
Benzalkonium chloride (%v/v) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Distilled water (ml) q. s. qs qs qs qs qs qs qs qs qs qs qs qs 
MO: Moringa olifera extract %w/v, ER: Embelia ribes extract %w/v 
 
Evaluation of thermoreversible in-situ nasal polyherbal gels 
Gelling temperature and gelling time 
Gelling temperature refers to the temperature when the meniscus of 
the formulation would no longer move upon slanting the test tubes 
at 90 ° angle. The gelling temperature was determined by placing the 
test tube, containing sufficient quantity of the prepared solutions, in 
a water bath at 4 °C. The temperature of water bath was increased 
slowly at a constant rate of 1 °C in every 2 min. 
Gelling time was recorded as the time for first detection of gelation. 
The sol-gel transition temperature (Tsol-gel) of the prepared in-
situ gel formulations was evaluated by transferring 2 ml of the 
prepared formulation to a test tube (10 ml), with a diameter of 1.0 cm. 
After sealing with a parafilm, the tube was kept in a circulation water 
bath at 37 °C. Following each temperature setting, equilibration was 
allowed for 10 min. Finally, the test tube was placed horizontally to 
observe the state of the sample and to examine the gelation. All the 
measurements were performed in triplicates.  
Viscosity of solution 
Viscosity of the in-situ gel systems was determined using Brookfield 
viscometer coupled with S-94 spindle (Brookfield Engineering 
Laboratories Inc., MA, USA). The prepared gel formulations were 
transferred to the beaker. The spindle was lowered perpendicularly 
into the gel at l00 rpm and temperature was maintained at 37±0.5 
°C. The viscosity was determined during the cooling of the system. 
All the measurements were performed in triplicates.  
Determination of pH 
One ml of the prepared gels was transferred to a 10 ml volumetric 
flask, and the solution was diluted with distilled water. The pH of 
resulting solution was determined using a digital pH meter (Elico 
LI120, India), which was previously calibrated using phosphate 
buffers at pH 4 and pH7. 
Drug content assay 
One ml of the prepared formulation was dispersed in 10 ml of methanol 
for 2–3 min with occasional shaking. The resulting solution was filtered 
through a 0.45 µm filter paper and was diluted with methanol. The 
amount of flavonoids present in the formulation was determined 
spectrophotometrically at 275 nm (Shimadzu UV1800, Japan).  
Gel strength 
Mucoadhesive strength 
Ex vivo mucoadhesive strength was determined using fresh sheep 
nasal mucosa. The mucosal membrane was separated by removing 
the underlying fat and loose tissues. The membrane was washed 
thrice with distilled water and phosphate buffer (pH 6.4). Modified 
balance method was used to design the experiment. 
The balance was equilibrated on both sides by placing one beaker on 
the left pan and a weight (5 g) on the opposite pan. The sheep nasal 
mucosa was cleaved into 1 cm2
A thin film of the prepared gel (1 g) was spread on the lower surface 
of the right pan. The right pan was lowered and was spread with gel 
by removing the beaker from the left pan. The pan was left 
undisturbed for 2 min to ensure proper contact between the nasal 
mucosa and the gel. Following this, water was slowly added to the 
left pan using a burette until the nasal mucosa was separated from 
 and glued with cyanoacrylate over 
the glass support to allow the smooth surface of nasal mucosa face 
the upper side of the glass. The glued sheep nasal mucosa was 
wetted with phosphate buffer (pH 6.4) by filling the beaker with the 
buffer on the right-hand side of the balance by lowering the glass 
support. The above setup was placed under the right side of the pan. 
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the gel film. The mucoadhesive force was calculated by determining 
the weight required to separate the mucosa. The force was 
expressed in dynes per square centimeter (dyne/cm2). 
Spreadability 
Spreadability was determined using a 10 × 4 cm rectangular glass 
slide. The sheep nasal mucosa from serosal side was tied on the 
surface of slide with a thread. The slide was kept in a hot air oven, at 
37 °C and one drop of gel was placed on the mucosa at an angle of 
120 °. Spreadability was determined relative to the distance 
travelled by the drop of gel (liquid) before its gelation. Average of 
three readings was recorded [12-16].  
Animals 
Healthy swiss mice (20-25 g), were obtained from the Centarl drug 
research institute (Lucknow, India). Prior to experimentation, the 
animals were quarantine for at least one week to a 12-h light/dark cycle 
All experimental protocols were from the CPCSEA (AUUP/AIP/ 
PhD/006/2017) and approved by Institutional Animal Ethics 
Committee. 
Irritancy study 
Mark an area (5 cm2
It is done by using swiss mice. The back skin of area of 5 cm
) on the left hand dorsal surface. The cream was 
applied to the specified area and time was noted. Irritancy, erythema, 
edema, was checked if any for regular intervals up to 24 h and reported.  
2
• Erythemia scale: none-0, slight-1, well defined-2, moderate-3, 
scar formulation-4. 
 is used. 
If the formulation produced scores of 2 or less they are considered 
to have no skin irritation [5, 6]. 
• Edema scale: none-0, slight-1, well defined-2, moderate-3, 
severe-4. 
RESULTS AND DISCUSSION 
Gelling temperature, gelling time and viscosity of in-situ nasal 
herbal gels  
The thirteen different in-situ nasal herbal gels were formulated 
using HPMC, carbopol and xanthan gum as the base polymers. The 
results of gelling temperature, gelling time and viscosity of herbal 
gels are demonstrated in (table 2). 
The gelling temperature of the in-situ nasal herbal gel ranged 
between 26.14 °C and 36.17 °C. The findings of the gelling 
temperature of prepared gel indicate that suitable for thermo 
reversible nasal gel.  
The gelling time of herbal gel ranged between 5.2 and 11.3 sec (table 
2). The gelling temperature of formulation was found to be within 
the range. The gelling time increases on decreasing the 
concentration of F4.  
The viscosity of the in-situ nasal herbal gels ranged between 30.2 
and 40.3 Pa·s. The viscosity of in-situ nasal herbal gels enhance on 
higher concentration of PF127. Similarly, on increasing the 
concentration of HPMC K4M/carbopol/xanthan gum, it enhances the 
viscosity of formulation. 
 
Table 2: Gelling temperature, gelling time and viscosity of solution thermo reversible in-situ nasal polyherbal gel formulations 
Formulation Gelation temperature ( °C) Gelling time (sec) Viscosity/(Pa·s) 
F1 26.14±0.25 5.2±0.05 40.3±0.82 
F2 29.35±0.47 7.5±0.08 35.7±0.15 
F3 32.52±0.63 8.1±0.02 32.3±0.37 
F4 36.17±0.43 11.3±0.6 29.5±0.64 
F5 31.24±0.81 9.1±0.07 32.2±0.84 
F6 30.83±0.51 8.5±0.02 32.4±0.39 
F7 29.45±0.64 6.2±0.04 32.9±0.67 
F8 32.18±0.38 10.5±0.14 31.5±0.53 
F9 31.38±0.43 9.3±0.09 31.8±0.45 
F10 31.02±0.37 7.6±0.11 32.1±0.68 
F11 33.41±0.95 10.8±0.04 30.2±0.47 
F12 32.52±0.17 9.7±0.17 30.4±0.92 
F13 31.61±0.58 8.5±0.13 30.5±0.48 
Values are mean±SD of three determinations 
 
Gel strength, ph and drug content of in-situ nasal herbal gel  
The outcomes of gel strength, pH and drug content of in-situ nasal 
herbal gel are displayed in (table 3). The gel strength of in-situ nasal 
herbal gel was ranged between 53.1 to 63.7s. It was observed on 
higher concentration of Carbopol 934 exhibited maximum gel 
strength. The addition of HPMC K4M/Carbopol/Xanthan gum in 
PF127 resulted to increase the gel strength.  
Gel pH was in the range of 5.2 to 5.9 which was in the range of pH at 
the absorption site (4.5-6.5). The drug content of the in-situ nasal 
herbal gels ranged between 90.4% and 93.4%. 
  
Table 3: Gel strength, pH and drug content of thermo reversible in-situ nasal polyherbal gel formulations 
Formulation pH Gel strength (s) Drug content 
F1 5.2±0.05 62.1±0.14 91.5±0.68 
F2 5.2±0.01 57.5±0.09 92.7±0.49 
F3 5.4±0.07 55.8±0.28 90.4±0.24 
F4 5.6±0.02 53.1±0.04 93.4±0.63 
F5 5.4±0.09 55.4±0.42 91.8±0.82 
F6 5.5±0.05 58.3±0.63 92.6±0.67 
F7 5.7±0.04 63.7±0.18 92.5±0.43 
F8 5.5±0.08 54.5±0.34 91.7±0.54 
F9 5.8±0.03 56.2±0.61 92.3±0.28 
F10 5.9±0.02 59.6±0.58 90.7±0.17 
F11 5.4±0.09 54.1±0.47 92.3±0.34 
F12 5.6±0.07 55.8±0.34 93.1±0.49 
F13 5.8±0.02 57.2±0.19 91.6±0.26 
 Values are mean±SD of three determinations 
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Mucoadhesive strength and spreadability of in-situ nasal herbal gel  
The findings of mucoadhesive strength and spreadability of in-situ 
nasal herbal gel are exhibited (table 4). The mucoadhesive strength 
was ranged between 6317.2 to 4236.7±0.61 dyne/cm2
 
. The higher 
concentration of Carbopol 934 produced greater mucoadhesive 
strength. Mucoadhesive drug delivery systems allows rapid 
dissipation of drug in the circulatory system, thereby preventing the 
first-pass metabolism and prolonging the residence time of the 
dosage at the site of application or absorption. In the present study, 
the formulations prepared with high concentration of HPMC/ 
carbopol/xanthan gum exhibited more mucoadhesion strength as 
compared to PF127 (10%). The spreadability of in-situ nasal herbal 
gel ranged between 7.6±0.21 to 11.7±0.65 cm. 
Table 4: Mucoadhesive strength and spreadability of thermoreversible in-situ nasal polyherbal gel formulations 
Formulation Mucoadhesive strength (dyne/cm2 Spreadability (cm) ) 
F1 6154.2±0.53 7.6±0.21 
F2 5236.8±0.29 9.2±0.53 
F3 4914.5±0.73 10.8±0.43 
F4 4236.7±0.61 12.3±0.17 
F5 4862.9±0.38 11.7±0.65 
F6 5543.4±0.92 11.1±0.34 
F7 6317.2±0.68 10.2±0.41 
F8 4567.5±0.51 10.7±0.57 
F9 5247.9±0.36 9.3±0.83 
F10 6153.3±0.18 8.8±0.19 
F11 4365.7±0.54 11.2±0.32 
F12 4739.2±0.32 10.5±0.48 
F13 5934.8±0.47 9.1±0.56 
 Values are mean±SD of three determinations 
 
Adverse effect of in-situ nasal herbal gel 
The in-situ nasal herbal gel show no redness, edema, inflammation 
and irritation during irritancy studies (table 5). The F3, F4, F6, F7, 
F12 and F13 produced slight irritation, edema and erythema, but it 
is acceptable.  
The prepared in-situ nasal herbal gels were safe to use. 
 
Table 5: Adverse effect thermo reversible in-situ nasal polyherbal gel formulations 
Formulations Irritant Erythema Edema 
F1 0 0 0 
F2 0 0 0 
F3 0 1 0 
F4 1 0 0 
F5 0 0 0 
F6 0 1 0 
F7 1 0 1 
F8 0 0 0 
F9 0 0 0 
F10 0 0 0 
F11 0 0 1 
F12 1 0 0 
F13 0 1 0 
 
In the past few years, an increasing number of in-situ gel forming 
systems have been reported for various biomedical applications, 
including drug delivery, cell encapsulation, and tissue repair. These 
were in the form of solutions, but gelation could occur in-situ by 
ionic cross-linking or a change of ph or temperature. The latter 
approach is based on temperature induced phase transition. The 
pluronics are made from ABA-type triblock copolymers containing 
PEO (A) and PPO units (B). Further the concentrated aqueous 
solutions of pluronic form thermo reversible gels.  
The gel containing pluronic produces weak mechanical strength, 
rapid erosion, and the non-biodegradability of PEO-PPO-PEO, which 
prevented the use of high molecular weight polymers. Hence, to 
minimize the associated drawback, it is required to formulate the 
pluronic with other bioadhesive polymers namely carboxymethyl-
cellulose (CMC), hydroxypropylmethyl cellulose (HPMC K4M), 
carbopol, xanthan gum, methyl methacrylate etc. We planned to 
restrain the viscoelastic properties and the bioadhesive 
characteristics of PF127 by forming dual systems with a high 
molecular weight HPMC K4M/Carbopol/xanthan gum [17, 18]. The 
object of the present study to formulate in-situ nasal herbal gel, 
modulating the viscoelastic properties and the bioadhesive 
characteristics of PF127by forming dual systems with a high 
molecular weight HPMC K4M or carbopol.  
Formulation of in-situ gels appears very attractive since it is fluid 
like prior to nasal administration and can thus easily be instilled as a 
drop allowing accurate dosing, but sets into a gel with increased 
residence time at body temperature.  
PF127 has excellent thermo sensitive gelling properties, low toxicity 
and irritation, excellent water solubility, good release characteristics 
and compatibility with other excipients. HPMC K4M/carbopol/ 
xanthan gum was selected as mucoadhesive agent. PF127 is more 
soluble in cold water than in hot water therefore gels were prepared 
by cold technique.  
Table 2 demonstrated with the increase of concentration of HPMC 
K4M or carbopol or xanthan gum, temperature was lessened and 
viscosity was raised moderately. Thus, packing of micelles and micelle 
entanglements might be the possible mechanisms of pluronic solution 
gelation with increase of temperature. PF127 solution behaves as a 
mobile viscous liquid at room temperature (25 °C), and transformed 
into a semi-solid transparent gel at body temperature (37 °C). Pluronic 
formulations generally increase drug residence time at application 
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sites through gelling, resulting in improved bioavailability and efficacy. 
Block copolymer PF127gels were thought to be formed by hydrogen 
bonding in aqueous systems, caused by the attraction of the pluronic 
ether oxygen atom of the ethyleneoxide chain with protons of the 
carbopol carboxylic groups or hydroxypropylmethyl cellulose 
hydroxyl groups, which contributed to the aggregation [17]. The 
desired gel strength may be achieved by combination of 2 polymers, 
so, PF127 concentration could be reduced to lower toxicity of huge 
PF127content.  
The experiments about effect of combination of bioadhesive agents 
and PF127 on gelation temperature and rheology behavior 
demonstrated that the packing and entanglements of micelles were 
promoted by adding either HPMC K4M or carbopol or xanthan gum, 
which accordingly lead to decrease of gelation temperature. There 
was some optimization about gelation temperature to ensure a 
solution at room temperature (25 °C), and a semi-solid transparent 
gel at body temperature (37 °C) [17]. These results suggested that 
the optimum concentration for HPMC K4M or carbopol or xanthan 
gum solution used in-situ gel forming system was 0.5%–1.5% (w/v), 
and that of pluronic F127 was below 10% (w/v). 
The viscosity of the formulated herbal gels was increased with the 
increment in the amount of hydroxypropylmethyl cellulose HPMC 
K4M or carbopol or xanthan gum. The viscosity was directly 
dependent on the bioadhesive content of the formulations. The 
hydroxypropylmethyl cellulose HPMC K4M or carbopol or xanthan 
gum can markedly prolong the residence time of the drugs in the nasal 
cavity because of their desirable mucoadhesive property. This can 
facilitate the sustained release of the drug can be maintained due to 
the high viscosity of the cellulose following hydration in the nasal 
cavity. Consequently, it increases the intranasal bioavailability of both 
small hydrophobic and hydrophilic macromolecular drugs [10, 19]. 
The presence of combination of HPMC K4M or carbopol or xanthan 
gum significantly increased the viscosity as well as gel strength. In 
addition, the formulations prepared with high concentration of 
HPMC K4M were associated less spread ability. This was attributed 
to the high viscous nature of HPMC K4M. The results of ph of the 
formulations did not show any mucosal irritation because all the 
formulations ph was within in the acceptable range. Formulation 
should possess mild acidic ph for activation of lysozyme (A natural 
antibacterial enzyme important for controlling nasal microbial count 
which becomes inactive at alkaline pH) [13]. 
Mucoadhesion involves 3 stages: wetting; interpenetration; and 
mechanical interlocking between mucin and polymer. Owing to the 
characteristic anatomy and physiology of the nasal passage, i.e., 
large surface area, highly vascularized epithelium, porous 
endothelial membrane, nasal drug delivery has emerged as a 
promising route of drug administration for the systemic therapy. 
The combination of HPMC K4M or carbopol or xanthan gum 
increases the mucoadhesive strength resulting to enhance the 
retention of drug in endothelial membrane [20]. The in-situ nasal 
herbal gel show no redness, edema, inflammation and irritation 
during irritancy studies, and it was safe to use. The in-situ nasal 
herbal gel prepared by combination of different concentration of to 
HPMC K4M or carbopol or xanthan gum with PF127 (10% w/v) 
produces the better and effective gel. The findings of evaluation 
parameter indicate that the in-situ gel prepared by combination 
with corbopol were better quality compared to HPMC K4M and 
xanthan gum. 
CONCLUSION 
The outcomes of the present study indicate that extract of Moringa 
olifera and Embelia ribes was successfully incorporated into the 
formulation to obtain in-situ nasal gel. The formulated in-situ nasal 
herbal gel showed good gelling temperature, gelling time, viscosity, 
gel strength, ph, drug content, mucoadhesive strength and 
spreadability. The novel mucoadhesive in-situ gels containing plant 
extract was developed to overcome the first-pass metabolism and 
enhance the subsequent low bioavailability of the drug. However, 
future in vivo studies are required to confirm these results.  
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